Home > Focus Areas > Multiple Myeloma Connect > Post
4yr
Impact of depression on adherence to lenalidomide plus low-dose dexamethasone in patients with relapsed or refractory myeloma
Source : https://link.springer.com/article/10.1007/s00520-021-06017-y
Purpose While continued lenalidomide and low-dose dexamethasone (Rd) treatment could improve survival outcomes for multiple myeloma (MM), the association of depression on the adherence to Rd regimen in myeloma patients has never been studied even though depression is a common symptom among MM patients.
-
Mark Fesler4yrAn interesting study linking mental health to long term medication adherence, an association that certainly makes clinical sense and an opportunity for providers in practice to screen for depression and intervene as appropriate